Patents by Inventor Herbert Jaksche

Herbert Jaksche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC AMIDES FOR USE AS PHARMACEUTICALS
    Publication number: 20100261758
    Abstract: Compounds of Formula (I) wherein R1 is aryl, cyclohexyl or heterocyclyl, or (C1-4)alkyl substituted by aryl, cyclohexyl or heterocyclyl, R2 is defined heterocyclyl, R3 is alkyl, aryl, cyclohexyl or heterocyclyl, or (C1-4)alkyl substituted by aryl, cyclohexyl or heterocyclyl, R4 is H or alkyl, or R3 and R4 together with the carbon atom to which they are attached are cycloalkyl fused with aryl, and their use as pharmaceuticals.
    Type: Application
    Filed: March 28, 2007
    Publication date: October 14, 2010
    Applicant: NOVARTIS AG
    Inventors: Luca Arista, Klemens Hogenauer, Niko Schmiedeberg, Gudrun Werner, Herbert Jaksche
  • N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors
    Patent number: 7781481
    Abstract: N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: August 24, 2010
    Assignee: Novartis AG
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of CCR9 activity
    Patent number: 7759390
    Abstract: Compounds of formula I, wherein one of R1 and R2 is thienyl which is substituted by halogen and the other of R1 and R2 is substituted phenyl, wherein the substituents are as defined in the claims, with the proviso that the phenyl group is substituted by at least a cyano, carboxy or (C1-4)alkyloxycarbonyl group, are inhibitors of CCR9 activity and useful for therapeutic treatment.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: July 20, 2010
    Assignee: Novartis AG
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080312313
    Abstract: A compound of formula (I), wherein the residues have various meanings, useful as pharmaceuticals.
    Type: Application
    Filed: December 22, 2006
    Publication date: December 18, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080300295
    Abstract: Compounds of formula I, wherein one of R1 and R2 is thienyl which is substituted by halogen and the other of R1 and R2 is substituted phenyl, wherein the substituents are as defined in the claims, with the proviso that the phenyl group is substituted by at least a cyano, carboxy or (C1-4)alkyloxycarbonyl group, are inhibitors of CCR9 activity and useful for therapeutic treatment.
    Type: Application
    Filed: December 22, 2006
    Publication date: December 4, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080275114
    Abstract: Compounds of formula (I), in which R1 and R2 are independently a substituted phenyl group, where the substituents are as defined in the claims and with the proviso that at least one of the substituents is a cyano, carboxy or (C1-4)alkoxycarbonyl group, are inhibitors of CCR9 activity useful for therapeutic treatment, particularly of irritable bowel disease.
    Type: Application
    Filed: December 22, 2006
    Publication date: November 6, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080269312
    Abstract: N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents.
    Type: Application
    Filed: December 12, 2006
    Publication date: October 30, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Monoclonal antibodies and their use
    Publication number: 20050163768
    Abstract: Monoclonal murine internal image anti-idiotypic antibodies (Ab2) to monoclonal antibodies BR55-2 (Ab1), process for the production thereof and use for prophylactic and/or therapeutic immunization against HIV-infections, against cancer of epithelial origin and against small cell lung cancer.
    Type: Application
    Filed: March 23, 2005
    Publication date: July 28, 2005
    Inventors: Helmut Eckert, Herbert Jaksche, Evelyne Janzek, Hans Loibner, Dieter Scholz
  • Monoclonal antibodies and their use
    Publication number: 20020146410
    Abstract: Monoclonal murine internal image anti-idiotypic antibodies (Ab2) to monoclonal antibodies BR55-2 (Ab1), process for the production thereof and use for prophylactic and/or therapeutic immunization against HIV-infections, against cancer of epithelial origin and against small cell lung cancer.
    Type: Application
    Filed: March 5, 2002
    Publication date: October 10, 2002
    Inventors: Helmut Eckert, Herbert Jaksche, Evelyne Janzek, Hans Loibner, Dieter Scholz